Skip to main content
. 2019 May 9;3(4):583–589. doi: 10.1007/s41669-019-0136-1

Table 2.

Total number of rapid review submissions received at the National Centre for Pharmacoeconomics during the 6-year period 2012–2017

Year Orphan (non-cancer) Orphan (cancer) Ultra-orphan Total
2012 3 2 0 26
2013 2 3 0 38
2014 5 4 1 54
2015 4 4 3 44
2016 3 4 3 51
2017 4 7 3 67
Total 21 (7.5%) 24 (8.6%) 10 (3.6%) 280 (100%)